Pramodini Medicare IPO

Pramodini Medicare IPO comprises a total issue size of 58,51,200 shares. The net offer to the public is 55,15,200 shares, after excluding 3,36,000 shares allotted on a firm basis. Of the Net offer 25,32,000 (45.91%) are allocated to QIB , 9,60,000 (17.41%) allocated to NII 20,23,200 (36.68%) allocated to RII .

Investors can bid for a minimum of 2,400 shares and in multiples of 1,200 shares thereof.

IPO Subscription Details

Incorporated in 2000, Pramodini Medicare Limited is a diagnostic service provider in India offering technology-enabled diagnostic services across radiology, clinical laboratory, and nuclear medicine segments. The company provides services to public hospitals, private hospitals, public sector undertakings (PSUs), medical colleges, and private diagnostic centres across tier I, II, and III cities.

Its service portfolio includes radiology services such as MRI, CT scans, X-ray, ultrasound with colour doppler, mammography, Dexa scan, and interventional radiology; clinical laboratory services including haematology, microbiology, immunology, pathology, and biochemistry; and nuclear medicine services such as PET-CT, SPECT, and nuclear therapy. The company also operates a 24×7 teleradiology unit from Vijayawada and a processing laboratory at the same location.

Service Model

Public-Private Partnership (PPP): Operates diagnostic centres within government hospitals and medical colleges through long-term MOUs.

Private-Private Partnership (Pvt-Pvt): Establishes and manages diagnostic centres inside private hospitals under partnership agreements.

Strategic Partnerships with PSUs: Collaborates with Government of India PSUs to operate diagnostic and imaging centres across multiple states.

Standalone Diagnostic Centres: Operates its own diagnostic centres and laboratories, serving both individual patients and hospitals.

Location-Specific Agreements: Each diagnostic centre operates under separate MOUs or contracts with terms customized for the respective location.

The business operates through four models: public-private partnership (PPP) with government hospitals and teaching institutions, private-private partnerships with hospitals, strategic partnerships with PSUs, and standalone private diagnostic centres. As of August 04, 2026, the company operated 16 diagnostic centres across seven states.

As of March 31, 2026, the company had 161permanent employees.

Competitive Strengths:

Establishing a strategic presence across various states of India.

Strengthening its network through diversified business models.

Strong technical capabilities supported by robust IT infrastructure.

Experienced management team with significant industry expertise.

Consistent track record of revenue growth and financial performance.

Diverse customer base, including hospitals, institutions, and individual patients.

Pramodini Medicare Ltd.'s revenue increased by 64% and profit after tax (PAT) rose by 56% between the financial year ending with March 31, 2026 and March 31, 2025.

View More »

The Pramodini Medicare IPO is subscribed 3.87 times on August 14, 2026 6:54:59 PM (Day 3). The public issue subscribed 3.49 times in the individual investors category, 3.66 times in the QIB category, and 4.96 times in the NII category. Check Day by Day Subscription Details (Live Status)

Reload

Total Applications: 3,689

*Market Maker portion is not included to NII/HNI.